[1]
Mallmann, Q. 2026. The Tension Between “Brand-Name” Drugs And “Generics”: The Pharmaceutical Industry’s Temporary Monopoly And The Public Domain – The Legal Regime For Invention Patents. Revista de Propriedade Intelectual, Direito Contemporâneo e Constituição. 15, 1 (Aug. 2026), e20261501005. DOI:https://doi.org/10.16928/e20261501005.